7Baggers
 aquestive therapeutics advances anaphylm clinical development  TipRanks Wed, 01 Oct 2025 17:10:56 GMT
 Aquestive Therapeutics SVP sells $63,000 in shares By Investing.com  Investing.com Nigeria Tue, 30 Sep 2025 03:03:24 GMT
 Aquestive Therapeutics CEO Barber sells $551k in shares By Investing.com  Investing.com Nigeria Tue, 30 Sep 2025 00:36:29 GMT
 aquestive therapeutics ceo barber sells $551k in shares by investing.com  Investing.com Nigeria Mon, 29 Sep 2025 20:37:30 GMT
 aquestive therapeutics svp sells $63,000 in shares  Investing.com Mon, 29 Sep 2025 20:32:00 GMT
 Aquestive Therapeutics Hits New 52-Week High of $6.43  Markets Mojo Mon, 29 Sep 2025 17:37:38 GMT
 published on: 2025-09-28 19:22:53  earlytimes.in Sun, 28 Sep 2025 13:52:53 GMT
 Aquestive Therapeutics Sees Stock Surge Following FDA Approval News  timothysykes.com Sun, 28 Sep 2025 13:14:00 GMT
 aquestive therapeutics sees stock surge following fda news  timothysykes.com Sat, 27 Sep 2025 16:16:00 GMT
 insider sell: daniel barber sells 91,343 shares of aquestive the  GuruFocus Fri, 26 Sep 2025 07:00:00 GMT
 Why Aquestive Therapeutics Stock Jumped After-Hours Today  Stocktwits Fri, 26 Sep 2025 04:22:00 GMT
 Aquestive Therapeutics (AQST) CEO Barber sells $2400 in stock  Investing.com Mon, 22 Sep 2025 07:00:00 GMT
 Aquestive Therapeutics Stock Soars on FDA Approval News  timothysykes.com Sun, 21 Sep 2025 07:00:00 GMT
 oppenheimer raises aqst target price, shares surge  StocksToTrade Sat, 20 Sep 2025 16:52:00 GMT
 FDA Approval Boosts Future Prospects for Aquestive Therapeutics  timothysykes.com Sat, 20 Sep 2025 07:00:00 GMT
 aquestive therapeutics (nasdaq:aqst) trading up 5.2% - here's why  MarketBeat Wed, 17 Sep 2025 07:59:50 GMT
 aquestive, veeva, oklo, biomarin, tko: trending by analysts  TipRanks Sat, 13 Sep 2025 13:28:21 GMT
 aquestive bets big on oral epinephrine’s market debut  Finimize Fri, 12 Sep 2025 00:38:45 GMT
 analysts offer predictions for aqst q3 earnings  MarketBeat Wed, 10 Sep 2025 07:00:00 GMT
 aquestive therapeutics svp sells $79,500 in shares by investing.com  Investing.com South Africa Tue, 09 Sep 2025 06:32:09 GMT
 aquestive therapeutics (aqst) coo jung cassie sells $310,900 in shares  Investing.com Tue, 09 Sep 2025 01:55:10 GMT
 Aquestive Therapeutics says FDA AdCom not needed for review of Anaphylm  The Pharma Letter Mon, 08 Sep 2025 07:00:00 GMT
 Aquestive Therapeutics SVP sells $79,500 in shares  Investing.com Mon, 08 Sep 2025 07:00:00 GMT
 Aquestive therapeutics (AQST) COO Jung Cassie sells $310,900 in shares  Investing.com Mon, 08 Sep 2025 07:00:00 GMT
 aquestive therapeutics highlights at global investor conference  TipRanks Mon, 08 Sep 2025 07:00:00 GMT
 fda won’t require advisory committee meeting for aquestive’s anaphylaxis film  Investing.com Canada Fri, 05 Sep 2025 09:34:48 GMT
 lake street reaffirms their buy rating on aquestive therapeutics (aqst)  The Globe and Mail Fri, 05 Sep 2025 07:00:00 GMT
 aqst stock up as fda skips advisory meeting to discuss anaphylm nda  Yahoo Finance Fri, 05 Sep 2025 07:00:00 GMT
 aquestive gains as allergy therapy undergoes fda review  MSN Fri, 05 Sep 2025 06:04:45 GMT
 aquestive gains as allergy therapy undergoes fda review  MSN Thu, 04 Sep 2025 21:48:20 GMT
 Aquestive Therapeutics Announces that FDA Will Not Require  GlobeNewswire Thu, 04 Sep 2025 07:00:00 GMT
 aquestive therapeutics awaits fda decision on anaphylm  TipRanks Thu, 04 Sep 2025 07:00:00 GMT
 aquestive jumps as fda says no adcom for allergy therapy anaphylm  Seeking Alpha Thu, 04 Sep 2025 07:00:00 GMT
 aquestive says no fda adcom for anaphylm (aqst:nasdaq)  Seeking Alpha Thu, 04 Sep 2025 07:00:00 GMT
 aquestive therapeutics shares rise, fda forgos meeting on anaphylm  MarketScreener Thu, 04 Sep 2025 07:00:00 GMT
 fda confirms direct review path for aquestive's allergy treatment  Yahoo Finance Thu, 04 Sep 2025 07:00:00 GMT
 gap, aquestive therapeutics, lumentum  TradingView Thu, 04 Sep 2025 07:00:00 GMT
 published on: 2025-09-03 22:42:37  Newser Thu, 04 Sep 2025 03:42:37 GMT
 published on: 2025-09-02 04:19:41  Newser Tue, 02 Sep 2025 09:19:41 GMT
 published on: 2025-08-31 21:41:37  Newser Mon, 01 Sep 2025 02:41:37 GMT
 published on: 2025-08-30 23:10:37  Newser Sun, 31 Aug 2025 04:10:37 GMT
 published on: 2025-08-30 21:44:45  Newser Sun, 31 Aug 2025 02:44:45 GMT

Aquestive Therapeutics, Inc
(NASDAQ:AQST) 

AQST stock logo

Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of le...

Founded: 2004
Full Time Employees: 232
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends